Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lyra Therapeutics

Clinical trials sponsored by Lyra Therapeutics, explained in plain language.

Lyra Therapeutics LYRA NASDAQ

A clinical-stage biopharmaceutical company developing therapies for chronic ear, nose, and throat diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

New sinus implant aims to unblock noses and ease facial pain

Symptom relief Completed

This study tested an experimental implant called LYR-210 in 182 adults with long-term sinus inflammation (chronic rhinosinusitis). The goal was to see if it could reduce key symptoms like nasal congestion, discharge, and facial pain better than a placebo. Participants received th…

Phase: PHASE3 • Sponsor: Lyra Therapeutics • Aim: Symptom relief

Last updated Jun 27, 2026 09:06 UTC